Genetic Testing

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing...

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide

-- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy --...

Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services

EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services...

Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028, Driven by Rising Adoption of Healthcare IT, Report with AI Impact on Trends – Technavio

NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global population health management...

Helio Genomics and Halub Medical Co. Announce Strategic Partnership to Commercialize HelioLiver Dx in The Gulf Cooperation Council and Middle East

IRVINE, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven biotechnology company specializing in...

AI-Driven Market Transformation, Europe’s Pharma E-Commerce to Grow by USD 38.7 Billion from 2024-2028, Boosted by Internet Accessibility

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global pharma e-commerce market...

error: Content is protected !!